Search This Blog

Monday, March 18, 2019

Dermira: All 3 doses of lebrikizumab met primary endpoint

https://thefly.com/landingPageNews.php?id=2880342
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)